Skip to main content

XOBET CREAM/ DPL-CLOBETASOL CREAM/ CLOXOBET CREAM/ XOBET OINTMENT/ DPL-CLOBETASOL OINTMENT/ CLOXOBET OINTMENT (Douglas Pharmaceuticals Australia Pty Ltd)

Product name
XOBET CREAM/ DPL-CLOBETASOL CREAM/ CLOXOBET CREAM/ XOBET OINTMENT/ DPL-CLOBETASOL OINTMENT/ CLOXOBET OINTMENT
Date registered
Evaluation commenced
Decision date
Approval time
217 (255 working days)
Active ingredients
Clobetasol propionate
Registration type
EOI
Indication

Short-term treatment of resistant or severe inflammatory and pruritic manifestations of steroid responsive dermatoses, including psoriasis (excluding widespread plaque psoriasis), recalcitrant dermatoses, lichen sclerosus/planus and discoid lupus erythematosus in adults.

Help us improve the Therapeutic Goods Administration site